Fixed-dose-rate gemcitabine: A viable first-line treatment option for advanced pancreatic and biliary tract cancer

Michele Milella, Alain J. Gelibter, Maria Simona Pino, Giandominik Bossone, Paolo Marolla, Isabella Sperduti, Francesco Cognetti

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Fixed-dose-rate gemcitabine: A viable first-line treatment option for advanced pancreatic and biliary tract cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences